
Frontera Therapeutics submitted a listing application to the Hong Kong Stock Exchange
36Kr learned that documents from the Hong Kong Stock Exchange show that Frontera Therapeutics has submitted a listing application to the Hong Kong Stock Exchange, with UBS Group AG and Guotai Haitong as joint sponsors

